Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 8/20 | 0.41 |
| ▸ | HTR2C | P28335 | 5/20 | 0.41 |
| ▸ | HTR2B | P41595 | 5/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27478040 | 1.00 | SLC6A4 (0.41) | SLC6A4HTR2CHTR2BMRGPRX4SLC6A2 | |
| SCHEMBL30740792 | 0.76 | SLC6A4 (0.47) | SLC6A4HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL30740789 | 0.75 | SLC6A4 (0.47) | SLC6A4HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL27478001 | 0.74 | USP30 (0.37) | SLC6A4HTR2CHTR2BMRGPRX4SLC6A2 | |
| SCHEMBL30742673 | 0.74 | USP30 (0.37) | SLC6A4HTR2CHTR2BMRGPRX4SLC6A2 | |
| SCHEMBL30740696 | 0.72 | SLC6A4 (0.44) | SLC6A4HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL27477980 | 0.72 | USP30 (0.38) | SLC6A4HTR2CHTR2BMRGPRX4 | |
| SCHEMBL30808487 | 0.71 | SLC6A4 (0.47) | SLC6A4HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL27111329 | 0.71 | SLC6A4 (0.47) | SLC6A4HTR2CHTR2BSLC6A2SLC6A3 | |
| SCHEMBL30742757 | 0.70 | MRGPRX4 (0.50) | SLC6A4HTR2CHTR2BMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562006-A1 | N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Carmot Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119923395-A | N-heterocyclic GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods of use thereof | 卡莫特医疗有限公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2024026338-A1 | N-HETEROCYLIC GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |